CDC Website CDC Website

To Join the NPIN community or

You are here

Commercial Organizations

HIV Vaccine Vector-Host Interactions: Understanding the Biology and Immunology (R01)

NPIN admin's picture
Grant Amount: Unspecified. The purpose of this Funding Opportunity Announcement (FOA) is to develop an increased understanding of the biology and immunology of natural viral infections and HIV vaccine vectors derived from these viruses. Applications should focus on four types of vaccine viral vector platforms developed from Adenoviridae, Poxviridae, Herpesviridae, and Adeno-associated viruses in humans or non-human primates (NHPs).

HIV Vaccine Vector-Host Interactions: Understanding the Biology and Immunology (R21)

NPIN admin's picture
Grant Amount: Unspecified. The purpose of this Funding Opportunity Announcement (FOA) is to develop an increased understanding of the biology and immunology of natural viral infections and HIV vaccine vectors derived from these viruses. Applications should focus on four types of vaccine viral vector platforms developed from Adenoviridae, Poxviridae, Herpesviridae, and Adeno-associated viruses in humans or non-human primates (NHPs).

HIV/AIDS Initiative for Minority Men (AIMM)

NPIN admin's picture
Grant Amount: Estimated $1,500,000 for competitive grants. The United States Department of Health and Human Services (HHS or Department), Office of Minority Health (OMH) located within the Office of the Secretary announces the anticipated availability of funds for Fiscal Year (FY) 2014 for HIV/AIDS Initiative for Minority Men (hereafter referred to as AIMM Initiative) under the authority of Section 1707 of the Public Health Service Act (42 U.S.C. §300u-6).

Clinical Trial Planning Grant for Interventions and Services to Improve Treatment and Prevention of HIV/AIDS (R34)

NPIN admin's picture
Grant Amount: Unspecified. This Funding Opportunity Announcement (FOA) invites Clinical Trial Planning Grant applications that propose planning, design, and preparation of documentation necessary for implementation of investigator-initiated clinical trials related to HIV treatment and prevention. This includes evaluating the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment, and includes populations with co-infections and comorbidities.

Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)

NPIN admin's picture
Grant Amount: NIDA intends to commit $1.5M in each fiscal year (FY 2015-2017) to fund 2-3 awards. Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies at the nexus of substance abuse and HIV/AIDS. This award is designed to support creative individuals who wish to pursue innovative research approaches for substance using populations with or at risk for HIV/AIDS.

Targeting Latently Infected Cells Without Reactivation (R01)

NPIN admin's picture
Grant Amount: NIAID intends to commit $2.7 million in FY2015 to fund 4-7 awards. The purpose of this Funding Opportunity Announcement (FOA) is to solicit innovative research that advances the understanding of mechanisms or approaches that could be harnessed to selectively eliminate HIV-1 latently-infected cells without depending on viral reactivation.

Advancing Structural Level Interventions Through Enhanced Understanding of Social Determinants in HIV Prevention and Care (R21)

NPIN admin's picture
Grant Amount: Unspecified. This Funding Opportunity Announcement (FOA) encourages applications that propose to understand and address social determinants associated with the prevention and treatment of HIV. This FOA describes two research endeavors that are unique and overlapping. The first is to characterize those social determinants that are most relevant to HIV prevention and treatment outcomes, particularly in their association with inequities in HIV risk or disease outcomes.

Advancing Structural Level Interventions Through Enhanced Understanding of Social Determinants in HIV Prevention and Care (R01)

NPIN admin's picture
Grant Amount: Unspecified. This Funding Opportunity Announcement (FOA) encourages applications that propose to understand and address social determinants associated with the prevention and treatment of HIV. This FOA describes two research endeavors that are unique and overlapping. The first is to characterize those social determinants that are most relevant to HIV prevention and treatment outcomes, particularly in their association with inequities in HIV risk or disease outcomes.

Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief...

NPIN admin's picture
Grant Amount: Approximate Current Fiscal Year Funding: $25,000,000; Approximate Total Project Period Funding: $125,000,000. The goals of this FOA are to: (1) Support the implementation of country-led, population-based HIV impact assessments to measure HIV-relevant services uptake and health outcomes and to monitor and inform policy and programming. (2) Strengthen host country capacity and skills to conduct population-based HIV impact assessments. (3) Use cost-effective, sustainable approaches and design elements leveraging current and evolving technologies.

Strengthening Adherence to Antiretroviral-Based HIV Prevention and Treatment (R01)

NPIN admin's picture
Grant Amount: Unspecified. This Funding Opportunity Announcement (FOA) encourages research to understand and promote adherence to antiretroviral (ARV) regimens for HIV treatment and prevention. Studies addressing pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) are the foci of this FOA. The overarching emphasis is on the development of feasible interventions to improve and sustain PrEP or ART adherence which could be rapidly implemented in clinical, community, and policy environments to improve HIV treatment and prevention outcomes.

Pages

Subscribe to RSS - Commercial Organizations